 |
|---|
Engagement of Investor Relations Firm Announced
|
VICTORIA, BC - October 6, 2003, CardioComm Solutions Inc. (TSX-V:CCG) (the "Company", "CardioComm"), announced today that it has entered into an Investor Relations agreement, effective October 1, 2003 with Current Capital Corp. (Current Capital) of Toronto, Ontario. Current Capital will receive $5,000 per month for a one-year period, plus approved expenses. Mr. John Robinson, principal owner of Current Capital, has advised the Corporation that at this time he does not own any CardioComm Solutions Inc. securities. Services to be provided by Current Capital include financial consulting, communications and investor relations consulting.
CardioComm has a patented and proprietary technology used in products for the recording, viewing, analyzing and storing of electrocardiograms (ECGs), for diagnosis and management of cardiac patients. CardioComm has achieved its technical goals of improved access and communication through the development of a real-time ECG viewer. It is the first company to provide a real-time means for physicians to view and control ECGs through LAN, WAN or the Internet, thereby creating a global virtual healthcare network. This technology is marketed as Global ECG Management System GEMS™ and GlobalCardio™. CardioComm's software products have been cleared for sale in the United States by the U.S. Food and Drug Administration. The Company has both ISO 9001 and EN 46001 certifications. More information about CardioComm can be found at www.cardiocomm.com.
Current Capital is a full-service investor relations and corporate communications firm that specializes in working with clients to effectively position them with current and prospective investors. With a broad range of clients -- small-cap to multinational, resource-based to high-tech, Current Capital's goal is to help clients build positive and enduring relationships with financial audiences. More information about Current Capital can be accessed at www.currentcapital.com.
Robert Kennedy, President of Current Capital said, "We are excited to have CardioComm as our new client. The healthcare industry is rapidly changing with the adoption of computer and Internet technology in efforts to reduce overall costs and improve patient care quality. With the high mortality rate of heart disease, we believe CardioComm's patented technology addresses a strong market need for better monitoring and management of cardiac patients." Current Capital Corp. will receive a monthly fee of $5,000.00 for the duration of the contract for investor relation services and, in addition, will be granted an option of up to 250,000 common shares of the corporation at an exercise price of $0.20 per share and a further 250,000 common shares at an exercise price of $0.35 per share, subject to board approval and the approval of applicable regulatory authorities.
Stephen Martin, President and CEO of CardioComm Solutions Inc. said, "CardioComm is pleased to retain the services of Current Capital. We believe Current Capital's investor relations program will help to significantly raise our corporate profile and develop public interest in our company." |
On behalf of the Board of Directors of CardioComm Solutions Inc.:
“Stephen Martin”
Stephen R. Martin, President & CEO
For investor information, please contact: Stephen Martin |
